Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States

…, N Siripong, J Wang, J Hicks, J Mehalko… - Science Translational …, 2021 - science.org
Asymptomatic SARS-CoV-2 infection and delayed implementation of diagnostics have led
to poorly defined viral prevalence rates in the United States and elsewhere. To address this, …

Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal Betacoronaviruses

…, H Kalish, A Shunmugavel, J Mehalko… - Journal of clinical …, 2021 - Springer
In order to properly understand the spread of SARS-CoV-2 infection and development of
humoral immunity, researchers have evaluated the presence of serum antibodies of people …

Long-range enhancers on 8q24 regulate c-Myc

…, MA Duhagon, K Banfield, J Mehalko… - Proceedings of the …, 2010 - National Acad Sciences
Recent genomewide association studies have found multiple genetic variants on chromosome
8q24 that are significantly associated with an increased susceptibility to prostate, …

Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling

…, S Hunsberger, K Snead, MP Fay, J Mehalko… - Nature …, 2021 - nature.com
The extent of SARS-CoV-2 infection throughout the United States population is currently
unknown. High quality serology is key to avoiding medically costly diagnostic errors, as well as …

Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assays

D Esposito, J Mehalko, M Drew, K Snead, V Wall… - Protein expression and …, 2020 - Elsevier
The SARS-CoV-2 spike trimer is the primary antigen for several serology assays critical to
determining the extent of SARS-CoV-2 exposure in the population. Until stable cell lines are …

[HTML][HTML] A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2

…, M Görges, VE Barakauskas, M Irvine, J Mehalko… - JCI insight, 2021 - ncbi.nlm.nih.gov
Preexisting cross-reactivity to SARS-CoV-2 occurs in the absence of prior viral exposure.
However, this has been difficult to quantify at the population level due to a lack of reliably …

[HTML][HTML] Standardization of enzyme-linked immunosorbent assays for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling

…, M Drew, S Hunsberger, K Snead, MP Fay, J Mehalko… - MedRxiv, 2020 - ncbi.nlm.nih.gov
The extent of SARS-CoV-2 infection throughout the United States population is currently
unknown. High quality serology is a key tool to understanding the spread of infection, immunity …

Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays

J Mehalko, M Drew, K Snead, JP Denson, V Wall… - Protein expression and …, 2021 - Elsevier
The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein is a commonly used
antigen for serology assays critical to determining the extent of SARS-CoV-2 exposure in the …

D614G spike variant does not alter IgG, IgM, or IgA spike seroassay performance

C Klumpp-Thomas, H Kalish, J Hicks, J Mehalko… - medRxiv, 2020 - medrxiv.org
Emergence of a new variant of spike protein (D614G) with increased infectivity and
transmissibility has prompted many to analyze the potential role of this variant in the SARS-CoV-2 …

The ribosomal S6 kinase 2 (RSK2)–SPRED2 complex regulates the phosphorylation of RSK substrates and MAPK signaling

…, DA Bonsor, MJ Sale, A Urisman, JL Mehalko… - Journal of Biological …, 2023 - ASBMB
Sprouty-related EVH-1 domain-containing (SPRED) proteins are a family of proteins that
negatively regulate the RAS-Mitogen-Activated Protein Kinase (MAPK) pathway, which is …